Webinar: How States Pay for Hep C Drugs Using a “Netflix-style” Subscription Model
Wednesday, May 15, 2019
3 p.m. (ET)
Faced with costly and effective treatment for hepatitis C, states are exploring innovative alternative payment methodologies (APMs) to expand access to treatment and generate savings. Using a “Netflix-style” subscription model, Louisiana and Washington are negotiating agreements with drug manufacturers to get unlimited access to hepatitis C drugs for a fixed, predetermined cost. Join this NASHP webinar to hear about Louisiana and Washington’s innovative APMs as well as related research into hepatitis C from the Patient-Centered Outcomes Research Institute (PCORI).
Moderator: Trish Riley, Executive Director, National Academy for State Health Policy
Speakers:
- Pete Croughan, Health Policy Advisor, Louisiana Department of Public Health
- Donna Sullivan, MS, PharmD, Chief Pharmacy Officer, Washington Health Care Authority
- Robyn Liu, MD, MPH, Assistant Professor of Family Medicine, School of Medicine, Oregon Health and Science University


For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































